{
    "title": "Celulact H",
    "inventor_name": "Ioan Istrate",
    "publication_year": 2000,
    "device_name": "Celulact H",
    "goal": "Provide a nutritional supplement that acts as a cellular biostimulator to treat cancer and a wide range of other diseases.",
    "problem_addressed": "Cancer, cirrhosis, leukemia, multiple sclerosis, osteoporosis, Parkinson's, diabetes, chronic hepatitis, ulcers, anemia, bronchitis, asthma, epilepsy and other serious illnesses that lack effective, low-side-effect treatments.",
    "concept_summary": "Celulact H is a mixture of C14-C18 monocarboxylic acids obtained by saponifying sheep tallow, separating the acids, and form them in gelatin capsules. The product is claimed to release hydrogen radicals that regenerate diseased cells, restore normal cellular structure, and stimulate the immune system.",
    "detailed_description": "The patented preparation uses a 6-L stainless-steel reactor. Water is boiled, caustic soda is added, then animal fat (sheep tallow) is saponified. After 3 h, NaCl is added and heating stopped. The soap-glycerin mixture is washed with a citric-acid solution to pH 5.5, allowing C14-C18 monocarboxylic acids to separate. The acids are washed, dried under vacuum, and collected as a solid (melting point 70-73  deg C, boiling 124-134  deg C). The final product is a yellow-brown solid, soluble in alkaline media, ether, benzene, halogenated solvents, and absolute ethanol. It is encapsulated in gelatin capsules and taken orally as a dietary supplement. The inventor claims that the acids generate hydrogen radicals that 'cut' a mayonnaise-like cellular matrix in the nucleus, thereby restoring normal cell function and eliminating tumor tissue.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Cellular biostimulation",
        "Hydrogen radical activation",
        "Monocarboxylic acid therapy"
    ],
    "scientific_domains": [
        "Medicine",
        "Pharmacology",
        "Biochemistry",
        "Chemical Engineering"
    ],
    "mechanisms_of_action": [
        "Release of hydrogen radicals that activate cellular repair pathways",
        "Restoration of normal nuclear matrix structure",
        "Regeneration of diseased cells",
        "Stimulation of immune system and blood formation"
    ],
    "materials": [
        "Sheep tallow (animal fat)",
        "Caustic soda (NaOH)",
        "Sodium chloride (NaCl)",
        "Citric acid",
        "Water",
        "Gelatin (for capsules)"
    ],
    "energy_sources": [],
    "inputs": [
        "Sheep tallow",
        "Water",
        "NaOH",
        "NaCl",
        "Citric acid"
    ],
    "outputs": [
        "C14-C18 monocarboxylic acids mixture",
        "Soap",
        "Glycerin"
    ],
    "claimed_performance": "Effective against a broad spectrum of cancers (lung, breast, liver, pancreas, bone, etc.) and other diseases; reported tumor shrinkage, remission, improved appetite, enhanced immune function, and overall revitalization of the body.",
    "experimental_evidence": "Anecdotal patient reports (e.g., NMR analysis showing no carcinoma hint, ultrasound indicating tumor disappearance), and subjective improvement statements. No controlled clinical trials or peer-reviewed data are presented.",
    "replication_status": null,
    "keywords": [
        "Celulact H",
        "monocarboxylic acids",
        "cancer treatment",
        "biostimulator",
        "sheep tallow",
        "natural supplement"
    ],
    "related_technologies": [
        "Saponification",
        "Acid extraction",
        "Nutritional supplements"
    ],
    "controversy_level": "high",
    "confidence_score": 0.6,
    "practicability_score": 0.5,
    "fringe_score": 0.8,
    "evidence_strength": 0.2,
    "risk_score": 0.4,
    "trl_estimate": 4,
    "source_urls": [
        "http://premonitii.ro/showthread.php?tid=20118",
        "http://www.formula-as.ro/2000/429/medicina-naturista-25/medicina-naturista-1685",
        "http://www.libertatea.ro"
    ],
    "organizations": [
        "Romanian Patent Office (OSIM)",
        "Central Industrial Medicines (Romania)"
    ],
    "applications": [
        "Cancer therapy",
        "Immune system support",
        "Nutritional supplementation"
    ],
    "limitations": [
        "Lack of peer-reviewed clinical data",
        "Evidence limited to anecdotal case reports",
        "Potential variability in acid composition",
        "No disclosed dosing regimen"
    ],
    "open_questions": [
        "What is the exact biochemical mechanism of hydrogen radicals in human cells?",
        "Can efficacy be demonstrated in randomized controlled trials?",
        "Are there any long-term safety concerns, especially for children?"
    ],
    "red_flags": [
        "Extraordinary claims of curing advanced cancers without rigorous evidence",
        "Reliance on anecdotal testimonials",
        "No published peer-reviewed studies or independent replication"
    ],
    "evidence_quotes": [
        "\"...the drug from the patent) against cirrhosis and cancer, with excellent effects on patients.\"",
        "\"...NMR analysis, which did not detect even a hint of carcinoma.\"",
        "\"...ultrasound result reveals that all bodies are perfect, there was no lymphadenopathy, the tumor is well localized and delimited.\"",
        "\"...the treatment can be done in parallel to allopathic medicine, but not with chemotherapy and irradiation because in some cases cancellation has occurred.\"",
        "\"...the acid obtained is a mixture of C4-C18 monocarboxylic acids, solid, yellow-colored, light brown, with a melting point of 70-73  deg C.\""
    ]
}